Immatics (IMTX) Other financing activities (2020 - 2025)
Immatics' (IMTX) quarterly Other financing activities came in at $3.8 million in Q4 2025, down 20.57% year-on-year from $4.8 million in Q4 2024, and up 1.48% quarter-over-quarter from $3.8 million in Q3 2025.
Immatics (IMTX) Other financing activities (2020 - 2025) Analysis & Trends
Immatics has disclosed Other financing activities across 6 years of filings, most recently posting $3.8 million for Q4 2025.
- Other financing activities for Q4 2025 came in at $3.8 million, down 20.57% year-over-year; the trailing twelve-month figure through Dec 2025 was $16.9 million (down 11.63% YoY), and the FY2025 annual result was $17.0 million, down 10.02% from the prior year.
- Other financing activities came in at $3.8 million for Q4 2025 at Immatics, up from $3.8 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $6.6 million in Q1 2023 to a low of -$15.3 billion in Q3 2022.
- The 5-year median for Other financing activities is $4.7 million (2024), against an average of -$1.1 billion.
- Across the five-year window, Other financing activities plunged 393.7% in 2023 and soared 127.64% in 2024, its largest moves.
- Immatics' Other financing activities stood at -$1.0 billion in 2021, then surged by 100.57% to $6.0 million in 2022, then slumped by 393.7% to -$17.5 million in 2023, then jumped by 127.64% to $4.8 million in 2024, then declined by 20.57% to $3.8 million in 2025.
- The last three Other financing activities figures came in at $3.8 million (Q4 2025), $3.8 million (Q3 2025), and $4.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.84 Mn |
| Dec 31, 2025 | 3.84 Mn |
| Sep 30, 2025 | 3.79 Mn |
| Sep 30, 2025 | 3.79 Mn |
| Jun 30, 2025 | 4.69 Mn |
| Jun 30, 2025 | 4.69 Mn |
| Mar 31, 2025 | 4.55 Mn |
| Mar 31, 2025 | 4.55 Mn |
| Dec 31, 2024 | 4.84 Mn |
| Dec 31, 2024 | 4.84 Mn |
| Sep 30, 2024 | 4.95 Mn |
| Sep 30, 2024 | 4.95 Mn |
| Jun 30, 2024 | 4.64 Mn |
| Jun 30, 2024 | 4.64 Mn |
| Mar 31, 2024 | 4.67 Mn |
| Mar 31, 2024 | 4.67 Mn |
| Dec 31, 2023 | -17.51 Mn |
| Dec 31, 2023 | -17.51 Mn |
| Sep 30, 2023 | 5.10 Mn |
| Sep 30, 2023 | 5.10 Mn |